Safety and durable immunogenicity of the TV005 tetravalent dengue vaccine, across serotypes and age groups, in dengue-endemic Bangladesh: a randomised, controlled trial

Authors:

Abstract
No abstract available
Funding Information
  • Johns Hopkins University
  • Johns Hopkins University Bloomberg School of Public Health (75N93019D00031)
  • National Institutes of Health
  • Division of Intramural Research (HHSN272200900010C)

This publication has 29 references indexed in Scilit: